These results indicate that APOE ε4 has a specific influence on tauopathy (NFTs) as well as a shared effect on both plaque and NFT development, whereas the PRS is more generally associated with an increased burden of Alzheimer’s disease neuropathology. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.